Learn more →
Back to Expert Scholars
radiation-oncology / radiation-oncologyProstate Cancer Radiotherapy

Anthony Zietman

安东尼·齐特曼

MD

🏢Massachusetts General Hospital, Harvard Medical School(麻省总医院,哈佛医学院)🌐USA

Professor and Radiation Oncologist教授兼放射肿瘤科医师

62
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Anthony Zietman is a leading radiation oncologist at Massachusetts General Hospital specializing in prostate cancer radiotherapy and hypofractionation. He has been a principal investigator in landmark clinical trials establishing modern standards for prostate cancer radiation dose and fractionation.

Share:

🧪Research Fields 研究领域

Radiation Oncology放射肿瘤学
Prostate Cancer前列腺癌
Hypofractionation大分割放疗

🎓Key Contributions 主要贡献

Prostate Cancer Dose Escalation

Led pivotal trials demonstrating that dose-escalated proton radiotherapy improves biochemical control in prostate cancer, establishing new standards for conformal radiotherapy delivery.

Hypofractionation

Contributed extensively to validating hypofractionated radiotherapy schedules for prostate cancer, enabling shorter treatment courses without compromising tumor control or toxicity profiles.

Representative Works 代表性著作

[1]

Conventional versus dose-escalating radiation therapy for prostate cancer: a randomized trial

JAMA (2005)

Landmark randomized trial demonstrating superiority of dose-escalated proton radiotherapy in prostate cancer biochemical control.

[2]

Hypofractionated radiotherapy for prostate cancer

Journal of Clinical Oncology (2016)

Established clinical evidence supporting hypofractionated schedules as safe and effective alternatives for prostate cancer management.

🏆Awards & Recognition 奖项与荣誉

🏆American Society for Radiation Oncology (ASTRO) Gold Medal
🏆ASTRO Fellow
🏆Harvard Medical School Teaching Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 安东尼·齐特曼 的研究动态

Follow Anthony Zietman's research updates

留下邮箱,当我们发布与 Anthony Zietman(Massachusetts General Hospital, Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment